InterVene
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2684 Middlefield Rd Ste E, Redwood City,...Phone Number
(650) 995-7137Website
www.intervene-med.comRevenue
<$5 MillionIndustry
About InterVene
InterVene, Inc., located in Redwood City, Calif., in the San Francisco Bay Area, was formed with assistance from the Stanford Biodesign Fellowship program and was a former Company-In-Residence at the Fogarty Institute for Innovation. Staffed by highly experienced interventional cardiovascular professionals and advised by accomplished venous thought-leading physicians, the company develops interventional technology for treatment and prophylaxis of the causes of CVI with a specific interest in deep veins and the more severe, challenging aspects of venous disease.Explore more
InterVene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to InterVene
Compare insights from companies similar to InterVene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
InterVene Tech Stack
A closer look at the technologies used by InterVene
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InterVene
Sign Up For FreeTo access detailed company insights
InterVene, Inc., located in Redwood City, Calif., in the San Francisco Bay Area, was formed with assistance from the Stanford Biodesign Fellowship program and was a former Company-In-Residence at the Fogarty Institute for Innovation. Staffed by highly experienced interventional cardiovascular professionals and advised by accomplished venous thought... Read More
